LONDON: Britain is in talks with AstraZeneca for additional doses of its COVID-19 vaccine that will have been modified to better target Beta coronavirus, health minister Matt Hancock said Wednesday. The Beta coronavirus variant was first identified in South Africa. Britain has previously secured 100 million doses of the vaccine, developed at the University of Oxford and